dc.creatorHoussay, Bernardo Alberto
dc.date.accessioned2022-01-20T00:35:44Z
dc.date.accessioned2022-10-15T13:55:43Z
dc.date.available2022-01-20T00:35:44Z
dc.date.available2022-10-15T13:55:43Z
dc.date.created2022-01-20T00:35:44Z
dc.date.issued1947
dc.identifierHoussay, Bernardo Alberto; Alloxan diabetes; Canadian Medical Association; Canadian Medical Association Journal; 56; 5; 1947; 519-523
dc.identifier0008-4409
dc.identifierhttp://hdl.handle.net/11336/150366
dc.identifier0008-4409
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4393875
dc.description.abstractThe intravenous injection of alloxan induces a triphasic modification of the blood sugar level; (a) initial hiperglicemia; (b) secondary hypoglycemia; and (c) final hyperglycemia. The liver is essential for the initial hyperglycemia since this does not appear in hepatectomized dogs or toads or in eviscerated dogs. The initial hyperglycemia was observed in dogs after splanchnicectomy in adrenalectomized dogs or toads but not in adrenalectomized rats. In the dog the injection of alloxan produces a rise in blood pressure which is not due to the liberation of adrenaline as shown by suprareno-jugular anastomosis (Houssay and Rapela, unpublished data).
dc.languageeng
dc.publisherCanadian Medical Association
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590737/?page=1
dc.relationinfo:eu-repo/semantics/altIdentifier/pmid/https://pubmed.ncbi.nlm.nih.gov/20294606/
dc.relationCiudad de Buenos Aires
dc.relationFundacion Williams.
dc.relationFundación de Instituto de Biología y Medicina Experimental
dc.relationConsejo Nacional de Investigaciones Científicas y Técnicas
dc.relationProyecto Houssay y Leloir
dc.relationIBYME
dc.relationAR02675-3ACder-0331
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHOUSSAY, BERNARDO A.
dc.subjectHOUSSAY EL INVESTIGADOR
dc.subjectEL INVESTIGADOR
dc.subjectPUBLICACIONES CIENTIFICAS
dc.subjectPUBLICACIONES
dc.subjectDIABETES
dc.subjectALLOXAN
dc.subjectHYPERGLYCEMIA
dc.subjectHYPOGLYCEMIA
dc.subjectBLOOD SUGAR LEVEL
dc.titleAlloxan diabetes
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución